Companies that actually survive and flourish are going to change their business model from production to aggregating the networks and the network services and solutions. If you're a construction company or an IT company or a logistics company or an information data operation, to the extent that you can find ways to help build the commons, you can get some commercial value in that.

The antitrust litigation currently in the federal courts in the U.S. against Monsanto will be the test case in the life sciences, just as the Microsoft case was the test case in the information sciences.

You can eliminate, for example, a Brazil nut gene if you know that it will create an allergenic effect.

We're creating multiple personas. We're creating a thespian sense of personality where we see ourselves as works of art, and we see everything in our environment as a prop, as a set, as a stage, as a backdrop for filling ourselves in. We don't see ourselves as ever completed. We are in-formation.

It may be that everything the life science companies are telling us will turn out to be right, and there's no problem here whatsoever. That defies logic.

Europe will not accept genetically modified foods. It doesn't make any difference in the final analysis what Brussels does, what Washington does, or what the World Trade Organization does.

The EU Constitution is something new in human history. Though it is not as eloquent as the French and U.S. constitutions, it is the first governing document of its kind to expand the human franchise to the level of global consciousness. The language throughout the draft constitution speaks of universalism, making it clear that its focus is not a people, or a territory, or a nation, but rather the human race and the planet we inhabit.